Vibrio parahaemolyticus, which causes gastroenteritis, wound infection, and septicemia, has two sets of type III secretion systems (TTSS), TTSS1 and TTSS2. A TTSS1-deficient vcrD1 mutant of V. parahaemolyticus showed an attenuated cytotoxicity against HEp-2 cells, and a significant reduction in mouse lethality, which were both restored by complementation with the intact vcrD1 gene. V. parahaemolyticus also triggered phosphorylation of mitogenactivated protein kinases (MAPKs) including p38 and ERK1/2 in HEp-2 cells. The ability to activate p38 and ERK1/2 was significantly affected in a TTSS1-deficient vcrD1 mutant. Experiments using MAPK inhibitors showed that p38 and ERK1/2 MAPKs are involved in V. parahaemolyticus-induced death of HEp-2 cells. In addition, caspase-3 and caspase-9 were processed into active forms in V. parahaemolyticus-exposed HEp-2 cells, but activation of caspases was not essential for V. parahaemolyticusinduced death of HEp-2 cells, as shown by both annexin V staining and lactate dehydrogenase release assays. We conclude that secreted protein(s) of TTSS1 play an important role in activation of p38 and ERK1/2 in HEp-2 cells that eventually leads to cell death via a caspaseindependent mechanism.
Vibrio parahaemolyticus is a Gram-negative bacterium commonly found in marine and estuarine environments [8] . Infections with V. parahaemolyticus arise from the consumption of raw or undercooked shellfish and typically result in gastroenteritis that can be life-threatening to individuals who are immunocompromised or have preexisting medical conditions such as liver disease or diabetes [18, 20] .
A distinct characteristic of clinical V. parahaemolyticus strains is the production of thermostable direct hemolysin (TDH) [10] . TDH is one of the important virulence factors of this bacterium, because purified TDH elicits a number of biological effects including erythrocyte lysis, cardiotoxicity, chloride ion secretion, and fluid accumulation in the ileal loop model [19, [24] [25] [26] [27] . However, V. parahaemolyticus strains that lack the TDH and TDH-related hemolysin retain cytotoxicity in infection models using tissue cultures, indicating the presence of other cytotoxic factor(s) in this pathogen [14, 23] .
The type III secretion system (TTSS) present in several Gram-negative pathogens is also a determinant of virulence since this bacterial machinery delivers effectors of V. parahaemolyticus into the host cells, resulting in modulation of host components including the cytoskeleton and signal transduction [11] . Whereas the genes encoding the secretion apparatus are conserved, genes encoding effectors are unique to different microorganisms [28] . Genome sequencing of V. parahaemolyticus RIMD2210633 has revealed two sets of TTSS, TTSS1 and TTSS2 [15] . TTSS1 is similar to the Ysc secretion system of Yersinia, whereas TTSS2 shows homology with the Inv-Mxi-Spa secretion systems of Salmonella and Shigella. Investigations using mutant V. parahaemolyticus lacking TDH and one of the TTSSs, indicated that TTSS1 plays an important role in cytotoxicity against tissue culture cells, whereas TTSS2 is associated with bacterial enterotoxicity in the rabbit ileal loop model [15, 23] .
Among the components of V. parahaemolyticus TTSS1, VcrD1 protein is the most highly conserved compared with those of other bacteria, ranging from 41% identity with MxiA of S. flexneri to 94% identity with EscV of V. harveyi. Based on the structure of Yersinia TTSS, VcrD is predicted to be an inner membrane protein comprising the TTSS1 apparatus (http://www.genome.jp). In this study, we constructed a TTSS1-deficient V. parahaemolyticus strain with intact TDHs by directed mutagenesis of the vcrD1 gene, and used this strain to determine the role of TTSS1 in V. parahaemolyticus-induced death of HEp-2 cells. In addition, we defined the roles of two host signaling pathways, caspases and MAPKs, in V. parahaemolyticusinduced death of HEp-2 cells.
MATERIALS AND METHODS

Bacterial Strains, Plasmids, and Culture Conditions
The strains and plasmids used in this study are listed in Table 1 . Escherichia coli strains used for plasmid DNA preparation and the conjugational transfer of plasmid were grown in Luria-Bertani (LB) broth (1% bacto-tryptone, 0.5% yeast extract, and 1% NaCl) or on LB plate containing 1.5% agar. V. parahaemolyticus RIMD2210633 (ATCC number BAA-238) was used as the wild-type in this study, and was cultured in LB medium supplemented with additional 2% NaCl (LBS). Ampicillin was added to the medium at 100 µg/ml for the maintenance of plasmids in E. coli. Chloramphenicol at a concentration of 2 µg/ml was used for selection of V. parahaemolyticus exconjugants. All medium components were purchased from Difco (Lowrence, KS, USA), and the chemicals and antibiotics were from Sigma (St. Louis, MO, USA).
Cultivation of Cell Lines
HEp-2 cell line (ATCC No. CCL-23) derived from human epithelial cells was cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco BRL, Karsruhe, Germany) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin G, and 100 µg/ml streptomycin. The cells were maintained at 37 o C in a humidified atmosphere containing 5% CO
2
. FBS and DMEM were obtained from Hyclone (Logan, UT, USA).
Construction of ∆vcrD1 V. parahaemolyticus, NK-1, and Complementation Strain Chromosomal DNA isolated from V. parahaemolyticus RIMD2210633 was used as the template for PCR. A 704 bp vcrD1 upstream region was amplified using the primers VP1662A (5'-GATCGAGCTCCAT TGAAGCCTTTACTCACGT-3') and VP1662B (5'-GATCCTGCAG TCAACTTATTCATGAGATTC-3'). The resultant PCR product was digested with the appropriate restriction enzymes, SacI and PstI, and ligated to plasmid pBluescript SKII (+) to produce pSKvcrD1up. A 702 bp DNA fragment was amplified using primers VP1662C (5'-GATCCTGCAGTTGGACGGGTAGGGATGTAA-3') and VP1662D (5'-GATCGGGCCCT GCCTGCGGCGCTGAACTTC-3'), which is located downstream of the vcrD1 open reading frame (ORF). This PCR product was digested with PstI and ApaI, and cloned into pSKvcrD1up, resulting in pSKvcrD1updown. Finally, a 1.4 kb DNA fragment of pSKvcrD1updown was inserted into the SacI and ApaI sites of pDM4 [17] to yield pDM∆vcrD1. Plasmid pDM∆vcrD1 in the SM10 λpir strain [16] was mobilized to V. parahaemolyticus RIMD2210633, and the exconjugants were selected by plating the conjugation mixture of E. coli and V. parahaemolyticus on thiosulfate citrate bile sucrose (TCBS) agar plates supplemented with 2 µg/ml of chloramphenicol. A colony with characteristics indicating a double homologous recombination event (resistance to 10% sucrose, and sensitivity to chloramphenicol) was further confirmed by PCR using primers VP1622A and VP1622D, and the corresponding mutant strain was named NK-1 (Fig. 1A) .
A 2,186 bp DNA fragment containing an ORF and a 36 bp upstream region of the vcrD1 gene was amplified from V. parahaemolyticus genomic DNA using two primers, VP1662E (5'-CGGCCGCCAAG CGCATCGACGCTATC-3') and VP1662F (5'-GGGGTACCGATTG TACAAGTGCTGCGTTC-3'). This DNA fragment was cloned into For complementation strains, wild-type strain carrying pRK415, NK-1 carrying pRK415, and NK1 carrying pRKvcrD1, the supernatants of the HEp-2 cells infected at MOI 200 were harvested at 6 h and 8 h post-infection, and assayed for LDH release as described above.
Generation of apoptotic cells following exposure to V. parahaemolyticus was monitored using annexin V staining. HEp-2 cells were seeded at 1 × 10 A. A suicide plasmid containing upstream and downstream regions of the vcrD1 gene was constructed and used to generate a ∆vcrD1 mutant of V. parahaemolyticus via an allelic exchange of the ∆vcrD1 region with the homologous region of the V. parahaemolyticus chromosome. B. The adjacent region of the vcrD1 locus was amplified from wild-type (lane 1) and ∆vcrD1 V. parahaemolyticus (lane 2) by PCR using primers, VP1622A and VP1622D. SM represents the DNA size marker, 1 kb DNA ladder. C. Western blot analysis of secretomes of wild-type (lane 1) and NK1, the ∆vcrD1 V. parahaemolyticus (lane 2), using polyclonal Ab against VopQ, an effector of TTSS1.
were detected by staining with annexin V (BD Pharminogen, Palo Alto, CA, USA) at a final concentration of 2 µg/ml, and the degree of cell death was assessed using fluorescence-activated cell sorting (FACS) analysis. FACS analyses were performed on at least 10,000 cells per sample with a FACScan (Becton Dickinson, Franklin Lakes, NJ, USA).
Mouse Lethality Experiment
Specific-pathogen-free, 7-week-old female ICR mice (CrljOri:CD1[ICR]) were used to test the pathogenicity of various V. parahaemolyticus strains (wild-type, ∆vcrD1 mutant NK1, wild-type carrying pRK415, NK1 carrying pRK415, and NK1 carrying pRKvcrD1). V. parahaemolyticus was grown overnight in LBS medium, freshly inoculated into the same medium, and harvested when bacterial growth reached an OD Supernatant containing 20 µg of the total protein was separated by SDS-PAGE, and transferred onto a PVDF membrane. Membranes were blocked with 5% skim milk in TBST, and then incubated overnight at 4 o C with primary Ab specific to phosphorylated p38, phosphorylated ERK1/2, phosphorylated JNK MAPK, caspase 3, or caspase 9. After incubation with HRP-conjugated secondary Ab, immunoreactive bands were visualized using an enhanced chemiluminescence system (Cell Signaling Technology, Beverly, MA, USA). Membranes were then incubated in a stripping buffer (100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM Tris-HCl, pH 6.7) at 56 o C for 30 min, and probed with Ab against p38 MAPK, ERK1/2, or JNK. Rabbit polyclonal Abs against p38, phospho-p38, JNK, phospho-JNK, ERK1/2, phospho-ERK1/2, caspase 3, and caspase 9 were purchased from Cell Signaling Technology (Beverly, MA, USA). The level of β-actin in the cell extracts used for Western blot analysis was also determined as a loading control.
Pretreatment of HEp-2 Cells with Various Inhibitors
To investigate the roles of various signaling components in V. parahaemolyticus-induced cell death, HEp-2 cells were treated with selective inhibitor(s) prior to incubation with V. parahaemolyticus and their viabilities were compared with those of untreated cells using LDH assays as described above. The following inhibitors were purchased from Calbiochem (Schwalbach, Germany): z-VAD-FMK, a pan caspase inhibitor; SB202190, a selective inhibitor of p38 MAPK; SP600125, a selective inhibitor for JNK; and PD98059, an inhibitor of MAPK kinase.
HEp-2 cells were pretreated for 30 min with each of the following inhibitors at the indicated concentrations; z-VAD-FMK at 1-100 µM, SB202190 at 1-20 µM, SP600125 at 1-20 µM, and PD98059 at 1-20 µM. In all experiments, the chemicals were added as a dissolved form in dimethylsulfoxide (DMSO), and the concentration of DMSO did not exceed 1% of the culture volume, a concentration that did not affect any cellular processes of HEp-2 cells.
Statistical Analysis
Data are presented as the mean ± standard deviation from three independent experiments. Statistical analysis was performed using Student's t test (SYSTAT, SigmaPlot version 11; Systat Software Inc., Chicago, IL, USA) to evaluate the statistical significance of the results.
Differences were considered significant when P <0.05. Data with P <0.01 are indicated with two asterisks, whereas data with P-values between 0.01 and 0.05 are indicated with a single asterisk.
RESULTS
Confirmation of TTSS1-Defective Mutant V. parahaemolyticus Strain Among the two TTSSs found in V. parahaemolyticus, the role of TTSS1 was specifically examined in this study. Since the vcrD1 gene encodes a component of TTSS1 that is highly conserved in various Gram-negative bacteria [21] , a TTSS1-deficient mutant of V. parahaemolyticus was made by deleting the vcrD1 gene. The putative VcrD1 ORF (VP1622) was deleted from the genomic DNA of V. parahaemolyticus, as confirmed by PCR using primers VP1622A and VP1622D specific to the upstream and downstream regions of the deleted vcrD1 ORF, respectively. As expected, a 3,490 bp PCR product was amplified from wild-type DNA, whereas a smaller PCR product of 1,406 bp was produced from ∆vcrD1 mutant V parahaemolyticus, NK1 (Fig. 1B) .
To confirm that the ∆vcrD1 mutant V. parahaemolyticus strain NK1 lost the function of TTSS1, secreted proteins from the ∆vcrD1 mutant were harvested and analyzed by Western blot using anti-VopQ Ab (Fig. 1C) , clearly showing that secretion of VopQ was abolished in the NK1 strain.
Role of TTSS1 in Bacterial Cytotoxicity to HEp-2 Cells
Earlier studies have shown that ∆tdhS ∆tdhA V. parahaemolyticus induces apoptotic death of the epithelial cells and that TTSS1 plays an important role in this process [21, 23] . In the present study, we examined the role of TTSS1 in V. parahaemolyticus-induced death of HEp-2 cells in a genetic background with wild-type tdhS and tdhA genes. HEp-2 cells were treated with wild-type V. parahaemolyticus or ∆vcrD1 V. parahaemolyticus at a MOI of 200 for various exposure times (2-12 h), and the cytotoxicity of the bacteria against HEp-2 cells was determined by LDH release assay (Fig. 2A) . For wild-type V. parahaemolyticus, the percentage of LDH release gradually increased up to 85% as the incubation time increased. In contrast, the ∆vcrD1 mutant strain showed an attenuated ability to induce LDH release from the HEp-2 cells at all time points of infection (<10%). This result clearly indicates that V. parahaemolyticus is able to induce death of HEp-2 cells and that TTSS1 is one the main factors responsible for its cytotoxicity.
To confirm that the dysfunction of TTSS1 in the ∆vcrD1 mutant is derived from absence of the vcrD1 gene, a complementation plasmid containing wild-type vcrD1 gene was transformed into the ∆vcrD1 mutant V. parahaemolyticus ( Fig. 2B) . Incubation with wild-type V. parahaemolyticus carrying the vector plasmid pRK415 at MOI 100 or 200 for 6 h resulted in 28% or 43% LDH release, respectively. The cytotoxicity of NK1 carrying pRK415 was low, but increased in a MOI-dependent manner (3% at MOI 100 versus 9% at MOI 200). We then examined whether the decreased cytotoxicity of the DvcrD1 mutant could be recovered by the introduction of a complementation plasmid, pRKvcrD1. Inclusion of the complementation plasmid in the ∆vcrD1 mutant increased LDH activity up to 67-82% of that of the wild-type strain carrying pRK415.
Effect of vcrD1 Mutation on V. parahaemolyticus Virulence in Mice
The role of V. parahaemolyticus TTSS1 in mouse lethality was then examined. Wild-type or ∆vcrD1 mutant V. parahaemolyticus was injected intraperitoneally into 10 female mice at a dose of 1.0 × 10 8 bacterial cells per mouse and the number of live mice was determined over a 20 h period following infection (Fig. 3A) . Compared with mice infected with wild-type V. parahaemolyticus, mice infected with the ∆vcrD1 mutant showed a significant reduction in lethality; all 10 mice infected with wild-type bacteria were dead at 16 h post-injection, whereas five of the 10 NK1-infected mice were still viable at 20 h post-injection.
The virulence of complemented and control V. parahaemolyticus strains was also tested in the mouse model (Fig. 3B ). Mice infected with the ∆vcrD1 mutant carrying pRK415 were slowly dead until 18 h post-injection. Mice inoculated with wild-type V. parahaemolyticus carrying pRK415 were all dead at 10 h post-infection. Although the complemented strain (the ∆vcrD1 mutant carrying pRKvcrD1) was efficient at killing mice, it was slightly less effective than wild-type V. parahaemolyticus carrying the vector plasmid pRK415, suggesting that introduction of plasmid containing the wild-type vcrD1 gene into the ∆vcrD1 mutant caused a partial, but significant, recovery of bacterial virulence in mice.
Activation of MAPK Pathway in HEp-2 Cells upon V. parahaemolyticus Infection MAPK is one of the main kinases triggering cellular responses to pathogenic organisms and is subdivided into three different forms; p38, ERK1/2, and JNK MAPKs [13] . We determined whether incubation of HEp-2 cells with V. parahaemolyticus triggers the activation of these three MAPKs. HEp-2 cells were incubated with wild-type V. parahaemolyticus for 6 h at various MOIs (10, 50, 100, and 200) and analyzed for the presence of phosphorylated forms of these MAPKs (Fig. 4A) . p38 MAPK was indeed In the case of NK1, the ∆vcrD1 mutant of V. parahaeomolyticus, the ability to trigger activation of p38 and ERK1/2 was reduced; although maximal activation of p38 and ERK1/2 was observed at MOIs of 200 and 100, respectively, the level of activation was lower than that in HEp-2 cells treated with wild-type bacteria.
Role of MAPK Activation in V. parahaemolyticusInduced Death of HEp-2 Cells
In subsequent experiments, we examined whether activation of MAPKs is important in V. parahaemolyticus-induced cell death. HEp-2 cells were pretreated with various concentrations (1 to 20 µM) of one of the selective MAPK inhibitors prior to incubation with wild-type V. parahaemolyticus. Bacterial cytotoxicity to HEp-2 cells was then monitored by measuring LDH release, and compared with LDH release from HEp-2 cells treated with DMSO.
HEp-2 cells pretreated with SB202190, a selective inhibitor of p38 MAPK, were incubated with wild-type V. parahaemolyticus and assayed for LDH release (Fig. 5A) . Inactivation of p38 MAPK by SB202190 decreased V. parahaemolyticus-induced cell death in a dose-dependent manner to 66% of the control level (LDH release of DMSOtreated HEp-2 cells) at 20 µM. Similarly, pretreatment with PD98059 (a selective inhibitor of ERK1/2) prior to incubation with V. parahaemolyticus decreased the percentage of LDH release to 39% of the control at 20 µM PD98059 (Fig. 5B) . In contrast, inactivation of JNK with SP600125 did not result in a decrease in V. parahaemolyticusinduced death of HEp-2 cells (Fig. 5C ). This result suggests that among the three MAPKs, p38 and ERK1/2 are involved in V. parahaemolyticus-induced death of HEp-2 cells.
HEp-2 cells infected with the ∆vcrD1 mutant V. parahaemolyticus showed a similar level of LDH release regardless of the presence of JNK or ERK1/2 inhibitor. However, LDH release induced by the NK1 strain decreased further to less than 7% in the presence of p38 inhibitor.
These data demonstrate that V. parahaemolyticus triggers activation of p38 and ERK1/2 in HEp-2 cells, eventually leading to cell death. Moreover, TTSS1 of V. parahaemolyticus has a differential effect on the two MAPKs, p38 and ERK1/2, with respect to cell death. That is, TTSS1 plays a significant role in ERK1/2-mediated cell death, whereas p38 functions independently from TTSS1 in this process. 
Measurement of Apoptosis of V. parahemolyticus-Infected
HEp-2 Cells by Annexin V Staining As a preliminary experiment to define the role of caspase(s) in V. parahaemolyticus-induced death of HEp-2 cells, we measured apoptosis in V. parahaemolyticus-exposed HEp-2 cells by staining with annexin V (Fig. 6) . At a MOI 100 of wild-type V. parahaemolyticus, 33% of the HEp-2 cells were stained with annexin V, whereas only 2% were stained following treatment with the NK1 strain. The role of VcrD1 in V. parahaemolyticus-induced apoptosis of HEp2 was confirmed by a complementation experiment; addition of the complementation plasmid pRKvcrD1 into the NK1 strain increased the percentage of annexin-V-stained cells from 2% to 13%. In the case of wild-type V. parahaemolyticus carrying pRK415, 17% of the HEp-2 cells were stained with annexin V.
Infection of HEp-2 cells with various V. parahaemolyticus strains at MOI 200 resulted in similar levels of annexin V staining at infection with MOI 100. The absence of an increase in the number of apoptotic cells at a higher MOI may reflect the increased number of necrotic cells, which can be stained with propidium iodide (data not shown).
Role of Caspase(s) in V. parahaemolyticus-Induced Death of HEp-2 Cells Caspase activation is frequently considered synonymous with apoptotic cell death. Therefore, we investigated whether V. parahaemolyticus activates two caspases, caspase 3 and caspase 9, in HEp-2 cells (Fig. 7A and 7B, respectively) . HEp-2 cells were incubated with V. parahaemolyticus for 6 h at various MOIs (from 10 to 200), and subjected to Western blot analysis using anti-caspase Abs. Activation of both caspase 3 and caspase 9 was clearly demonstrated by the appearance of smaller immunoreactive protein band(s) in the HEp-2 cells incubated with V. parahaemolyticus. HEp-2 cells treated with STS served as a positive control for caspase activation, showing degradation of both caspase 3 and caspase 9.
To examine whether caspase is involved in the V. parahaemolyticus-induced cell death, we treated HEp-2 cells with a pan-caspase inhibitor, z-VAD-FMK, and stained them with annexin V (Fig. 7C) . z-VAD-FMK significantly protected STS-treated cells from death, indicating efficient inhibition of activation of caspases as previously reported [2] . However, the pan-caspase inhibitor did not prevent annexin V staining of HEp-2 cells infected with wild-type V. parahaemolyticus.
The caspase-independent nature of V. parahaemolyticusinduced cell death was also examined using an assay to measure LDH release (Fig. 7D) . Consistent with the above results, treatment of HEp-2 cells with pan-caspase inhibitor did not affect LDH release upon infection with wild-type V. parahaemolyticus. Taken together, these data suggest that V. parahaemolyticus-induced cell death is a caspaseindependent process.
DISCUSSION
Protein secretion is a key factor in the interaction of pathogenic bacteria with host cells. The type III secretion system is considered a virulence determinant, since proteins secreted through this system act directly with host cell components to alter its immune and cellular responses against the pathogens [11] . Genomic sequencing of V. parahaemolyticus revealed the presence of two TTSSs, which are involved in translocation of microbial factors into the cytoplasm of the host cells [21, 23] . Most previous studies on the role of these systems in the pathogenesis of V. parahaemolyticus have been performed in strains lacking its main virulence factor, TDH. This study aimed to define the role of TTSS1 in the V. parahaemolyticushost interaction using V. parahaemolyticus in which TDHs are functional. In this study, we determined the cytotoxicity and mouse lethality of wild-type V parahaemolyticus and defined the function of two main signaling pathways, MAPK and caspase, in V. parahaemolyticus-induced death of the host cells. By comparing the ability of wild-type and TTSS1-defective V. parahaemolyticus bacteria to kill the host cells and activate these signaling pathways, we evaluated the involvement of TTSS1 effector(s) in these processes.
The attenuated virulence of the ∆vcrD1 mutant V. parahaemolyticus in both in vitro and mouse models was HEp-2 cells were co-cultured with various V. parahaemolyticus strains (wild-type, ∆vcrD mutant NK1, wild-type carrying pRK415, NK-1 carrying pRK415, and NK-1 carrying pRKvcrD1) for 6 h at MOIs 100 and 200. Dead cells were detected by staining with annexin V at a concentration of 2 µg/ml, and the degree of cell death was assessed using FACS analysis of at least 10,000 cells per sample. Data are shown with standard deviation for three independent experiments. MAPK ACTIVATION BY VIBRIO PARAHAEMOLYTICUS 911 restored fully or partially when a vcrD1 + -plasmid was maintained in the mutant (Fig. 2B and 3B, respectively) , indicating that VcrD1 is one of the main components of TTSS1. The importance of VcrD1 in TTSS1 was also confirmed by the defectiveness of VopQ secretion by the ∆vcrD1 mutant of V. parahaemolyticus (Fig. 1C) .
Since the V. parahaemolyticus strains used in this study retain wild-type loci of the tdhS and tdhA genes, secretion of TDHs is an important issue that should be addressed. However, TDHs have been shown to be secreted in a TTSS1-and TTSS2-independent manner and are postulated to be secreted via type II secretion system based on their putative signal peptide sequences [9] . Therefore, we can exclude the contribution of TDHs to the altered pathology demonstrated by the TTSS1-deficient V. parahaemolyticus.
Treatment with pan-caspase inhibitor did not affect the V. parahaemolyticus-induced LDH release and apoptosis of HEp-2 cells (Fig. 7C and 7D) . Therefore, even though we observed activation of caspases in V. parahaemolyticusexposed cells (Fig. 7A and 7B) , their activation appears to be unrelated to the cytotoxicity of V. parahaemolyticus, which occurs through a caspase-independent mechanism. V. parahaemolyticus-induced cell death has been investigated in detail, and these earlier studies showed that TTSS1 A. Activation of caspase 3 in HEp-2 cells treated with V. parahaemolyticus. B. Activation of caspase 9 in HEp-2 cells treated with V. parahaemolyticus. HEp-2 cells were incubated for 6 h with wild-type V. parahaemolyticus at various MOIs (10-200) and analyzed by Western blot using anti-caspase Abs. HEp-2 cells were treated with 5 µM STS for 30 min to serve as a positive control for caspase activation. C. Effect of the pan-caspase inhibitor, z-VAD-FMK, on V. parahaemolyticus-induced apoptosis of HEp-2 cells. HEp-2 cells were treated with various concentrations (1-50 µM) of z-VAD-FMK prior to incubation with wild-type V. parahaemolyticus for 6 h at MOI 100. As a control, HEp-2 cells were treated with 1% DMSO before incubation with V. parahaemolyticus. HEp-2 cells treated with 5 µM STS were included as a positive control to confirm the activity of pan-caspase inhibitor. Apoptotic cells were detected by annexin-V staining. FACS analyses were performed on at least 10,000 cells per sample with a FACScan. Results are representative of at least three independent experiments. D. Effect of the pan-caspase inhibitor z-VAD-FMK on V. parahaemolyticus-induced LDH release of HEp-2 cells. HEp-2 cells were treated with 100 µM z-VAD-FMK prior to incubation with wild-type V. parahaemolyticus for 6 h at MOI 100. As a control, HEp-2 cells were treated with 1% DMSO before incubation with V. parahaemolyticus. HEp-2 cells treated with 5 µM STS were included as a positive control to monitor the activity of pancaspase inhibitor. LDH activity released from lysed HEp-2 cells was measured using a CytoTox96 assay kit as described.
induces rapid cell death initiated by acute autophagy in a caspase-independent manner [5, 6] . Specifically, VopQ, one of the TTSS1 effectors, is responsible for V. parahaemolyticusinduced autophagy [4] . In addition, another TTSS1 effector, VopS, is involved in apoptosis of macrophages via suppression of NF-kB activation [3] and is also implicated in cell rounding and collapse of the actin skeleton by direct inhibition of Rho family GTPase in HeLa cells [7] . Inhibition of Rho GTPase by VopS is mediated by covalent modification of Rho with adenosine 5'-monophosphate [31] .
Among the three MAPKs, two MAPKs, p38 and ERK1/2, appeared to be important in V. parahaemolyticus-induced death ( Fig. 5A and 5B). However, inhibitors of p38 or ERK1/2 differentially affected the cytotoxicity of the ∆vcrD1 mutant V. parahaemolyticus. Treatment with p38 inhibitor decreased the cytotoxicity of both wild-type and the ∆vcrD1 mutant, suggesting that the cytotoxic factor whose function is modulated by p38 MAPK is not secreted via TTSS1. On the other hand, the ERK1/2 inhibitor did not decrease cytotoxicity of the ∆vcrD1 mutant, indicating that secretion of the cytotoxic factors controlled by ERK1/2 is mediated by TTSS1. Several proteins have been reported to be TTSS1 effectors, including VopQ (VP1680), VopR (VP1683), VopS (VP1686), and VopA (VPA1346) [21, 29] . Among these, VopA is a member of the family of YopJ-like proteins of Yersinia spp., which inhibits the MAPK and NF-kB signaling cascades resulting in inhibition of the host immune system [22] . V. parahaemolyticus YopA was shown to inhibit the MAPK pathway, but not the NF-kB pathway [30] , and inhibition of MAPK was subsequently shown to occur via YopA-mediated acetylation of MAPK kinase [29] . Therefore, VopA may be the cytotoxic factor affected by MAPK inhibitors, but we cannot exclude involvement of other factors in the MAPKmediated V. parahaemolyticus-induced death of HEp-2 cells.
In this study, we define the role of two host signaling pathways, caspase and MAPK, in V. parahaemolyticusinduced death of HEp-2 cells, and show that cytotoxicity is caspase-independent, ERK1/2-dependent, and p38-dependent. Moreover, the function of ERK1/2 in this process is mediated via TTSS1 effector(s). To fully understand the cytotoxicity of V. parahaemolyticus, extensive investigation should be performed on diverse microbial components, including secreted proteins, surface proteins, and effector proteins, of V. parahaemolyticus.
